Tiziana Life Sciences Developing TZLS-501 as a Potential Treatment for Coronavirus Patients

Go back to Tiziana Life Sciences Developing TZLS-501 as a Potential Treatment for Coronavirus Patients
(NASDAQ: TLSA) Delayed: 1.14 +0.04 (3.64%)
Previous Close $1.10    52 Week High $ 
Open $1.11    52 Week Low $ 
Day High $1.15    P/E N/A 
Day Low $1.11    EPS $ 
Volume 331,023